SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001357
Filing Date
2024-03-06
Accepted
2024-03-06 16:05:31
Documents
15
Period of Report
2024-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 27797
  Complete submission text file 0001683168-24-001357.txt   244268

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sbfm-20240304.xsd EX-101.SCH 3553
3 XBRL DEFINITION FILE sbfm-20240304_def.xml EX-101.DEF 26585
4 XBRL LABEL FILE sbfm-20240304_lab.xml EX-101.LAB 36550
5 XBRL PRESENTATION FILE sbfm-20240304_pre.xml EX-101.PRE 25209
16 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5445
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24725862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)